How ConsumerAffairs uses cookies

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link:

We're there for consumers when it counts — with the right information, right on time.

Donate to our work

Kristen Dalli

Independent journalism since 1998

Kyle James

70,000+ consumer news stories published

Mark Huffman

Your support helps us invest in our mission to empower consumers to make informed decisions.

ConsumerAffairs is a for-profit company. Your contribution is not tax deductible.

Propranolol capsules recalled over possible metal contamination

Image (c) ConsumerAffairs - Breckenridge Pharmaceutical recalls 60 mg propranolol capsules due to potential metal contamination, affecting patient safety and health.

Breckenridge’s nationwide recall involves one lot of the hypertension medication

  • Breckenridge Pharmaceutical is recalling one lot of 60 mg propranolol hydrochloride extended-release capsules over possible metal contamination.

  • The affected 100-count bottles carry lot number PK25110035 and expire in May 2029.

  • Patients should stop using the recalled capsules and promptly contact their health care provider for replacement instructions, the company said. 


Breckenridge Pharmaceutical is recalling capsules manufactured by Adare Pharma Solutions. The company’s press release warned that possible metal contamination could cause cuts in the mouth, esophagus, stomach or intestines.

The concern arose after metal was found in another lot that never reached the market. The recalled capsules shared material suspected of causing that contamination. Breckenridge reported no known related adverse events.

The affected bottles have National Drug Code 51991-817-01. They were shipped nationwide to wholesalers and pharmacies between Oct. 26 and Nov. 4, 2026.

Propranolol extended-release capsules are prescribed for conditions including high blood pressure and angina. Patients need prompt guidance on replacement medication: prescribing information warns that abruptly interrupting propranolol treatment can worsen angina and, in some cases, lead to a heart attack.

What consumers should do

The company says consumers should immediately stop taking product from the lot subject to this recall and contact their physician or healthcare provider for medical advice and replacement instructions. Consumers should return any unused portion of the affected product to the pharmacy where it was obtained.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product.

Wholesalers, pharmacies, and other retail entities should check inventory for the recalled lot, quarantine any affected product, and not distribute or dispense the affected product. Entities that further distributed the product should notify their sub-accounts to the retail level.

For questions or concerns regarding this recall, contact Qualanex, Breckenridge's designated recall service provider, Monday through Friday, 9:00 a.m. to 5:00 p.m. Eastern Time:


Stay informed

Sign up for The Daily Consumer

Get the latest on recalls, scams, lawsuits, and more

    By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

    Thanks for subscribing.

    You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

    Was this article helpful?

    Share your experience about ConsumerAffairs

    Was this article helpful?

    Share your experience about ConsumerAffairs